Labeling of Dendritic Cells and Lymphocytes With Iron Oxide MR Contrast Agents for Cellular MRI

被引：0
|
作者：
Kobavashi, Yasunobu [1 ,2 ]
Shimizu, Koichi [1 ,2 ,3 ]
Ohno, Satoshi [2 ,4 ]
Okuyama, Ryuji [2 ,5 ]
Imai, Kenichiro [2 ,5 ]
Ostapenko, Valentina V. [2 ]
Kobayashi, Tamiyo [6 ]
Aruga, Atsushi [2 ,7 ]
Tanigawa, Keishi [1 ,2 ]
机构：
[1] J B Therapeut Inc, Tokyo, Japan
[2] Biothera Clin, Tokyo, Japan
[3] Shin Itabashi Clin, Tokyo, Japan
[4] IREHMS Tokyo Womens Med Univ, Tokyo, Japan
[5] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan
[6] Olympus Corp, Tokyo, Japan
[7] Tokyo Womens Med Univ, CICT, Tokyo, Japan
来源：
JOURNAL OF IMMUNOTHERAPY | 2009年 / 32卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：947 / 947
页数：1
相关论文
共 50 条
  • [1] Iron oxide MR contrast agents for molecular and cellular imaging
    Bulte, JWM
    Kraitchman, DL
    NMR IN BIOMEDICINE, 2004, 17 (07) : 484 - 499
  • [2] Iron Oxide Based MR Contrast Agents: from Chemistry to Cell Labeling
    Laurent, S.
    Boutry, S.
    Mahieu, I.
    Vander Elst, L.
    Muller, R. N.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (35) : 4712 - 4727
  • [3] Iron oxide nanoparticles stabilized with dendritic polyglycerols as selective MRI contrast agents
    Nordmeyer, Daniel
    Stumpf, Patrick
    Groeger, Dominic
    Hofmann, Andreas
    Enders, Sven
    Riese, Sebastian B.
    Dernedde, Jens
    Taupitz, Matthias
    Rauch, Ursula
    Haag, Rainer
    Ruehl, Eckart
    Graf, Christina
    NANOSCALE, 2014, 6 (16) : 9646 - 9654
  • [4] The Evolution of Iron Oxide Nanoparticles as MRI Contrast Agents
    O'Shea, Aileen
    Parakh, Anushri
    Lahoud, Rita Maria
    Hedgire, Sandeep
    Harisinghani, Mukesh G.
    MRS ADVANCES, 2020, 5 (42) : 2157 - 2168
  • [5] Dendronized iron oxide nanoparticles as contrast agents for MRI
    Basly, Brice
    Felder-Flesch, Delphine
    Perriat, Pascal
    Billotey, Claire
    Taleb, Jacqueline
    Pourroy, Genevieve
    Begin-Colin, Sylvie
    CHEMICAL COMMUNICATIONS, 2010, 46 (06) : 985 - 987
  • [6] The Evolution of Iron Oxide Nanoparticles as MRI Contrast Agents
    Aileen O’Shea
    Anushri Parakh
    Rita Maria Lahoud
    Sandeep Hedgire
    Mukesh G. Harisinghani
    MRS Advances, 2020, 5 : 2157 - 2168
  • [7] Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents
    Frank, JA
    Zywicke, H
    Jordan, EK
    Mitchell, J
    Lewis, BK
    Miller, B
    Bryant, LH
    Bulte, JWM
    ACADEMIC RADIOLOGY, 2002, 9 : S484 - S487
  • [8] Optimal conditions for dendritic cells labeling with superparamagnetic iron oxide for cellular magnetic resonance imaging
    Kobayashi, Yasunobu
    Shimizu, Koichi
    Okuyama, Ryuji
    Imai, Kenichiro
    Ohno, Satoshi
    Ostapenko, Valentina V.
    Kobayashi, Tamiyo
    Aruga, Atushi
    Tanigawa, Keishi
    CANCER RESEARCH, 2010, 70
  • [9] Superparamagnetic Iron Oxide Nanoparticles as MRI contrast agents for Non-invasive Stem Cell Labeling and Tracking
    Li, Li
    Jiang, Wen
    Luo, Kui
    Song, Hongmei
    Lan, Fang
    Wu, Yao
    Gu, Zhongwei
    THERANOSTICS, 2013, 3 (08): : 595 - 615
  • [10] Magnetically labeled glial cells as cellular MR contrast agents
    Bulte, JWM
    Zhang, SC
    van Gelderen, P
    Herynek, V
    Jordan, EK
    Janssen, CHC
    Duncan, ID
    Frank, JA
    ACADEMIC RADIOLOGY, 2002, 9 : S148 - S150
12345